CVS HEALTH Corp
CVSNYSERetail-Drug Stores and Proprietary StoresFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026Score 12/3016% above fair value
$88.51−1.74 (-1.93%)
Close on Nov 2, 2026Market cap $113.20BP/E 23.5Yield 3.01%
Cvs Health Pharmacy & Consumer Wellness by Quarter
Pharmacy & Consumer Wellness — Cost of Products Sold ($M)
Cvs Health Pharmacy & Consumer Wellness: $27,282M in Q2 2026, down 1.0% from a year earlier.
Latest, Q2 2026
27,282
Period ended Jun 30, 2026
Change on a year earlier
-1.0%
27,554 in Q2 2025
History
32 quarters
Since Q3 2018
Sources
28
Documents cited below
Where the Q2 2026 figure comes from
“|| Cost of products sold | 27,282 | 27,554 | 53,072 | 53,358 | (272) | (1.0) | % | (286) | (0.5) | %”
Source: CVS Health 10-Q (2026-08-05) ↗
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Pharmacy & Consumer Wellness — Cost of Products Sold ($M) | Year on year | Source |
|---|---|---|---|---|
| Q2 2026 | Jun 30, 2026 | 27,282 | -1.0% | CVS Health 10-Q (2026-08-05) ↗ |
| Q1 2026 | Mar 31, 2026 | 25,790 | -0.1% | CVS Health 10-Q (2026-05-06) ↗ |
| Q4 2025 | Dec 31, 2025 | 30,578 | +14.5% | CVS Health 8-K (2026-02-10) ↗ |
| Q3 2025 | Sep 30, 2025 | 29,647 | +13.9% | CVS Health 10-Q (2025-10-29) ↗ |
| Q2 2025 | Jun 30, 2025 | 27,554 | +15.6% | CVS Health 10-Q (2026-08-05) ↗ |
| Q1 2025 | Mar 31, 2025 | 25,804 | +13.4% | CVS Health 10-Q (2026-05-06) ↗ |
| Q4 2024 | Dec 31, 2024 | 26,710 | +10.6% | CVS Health 8-K (2026-02-10) ↗ |
| Q3 2024 | Sep 30, 2024 | 26,032 | +14.2% | CVS Health 10-Q (2025-10-29) ↗ |
| Q2 2024 | Jun 30, 2024 | 23,835 | +5.3% | CVS Health 10-Q (2025-07-31) ↗ |
| Q1 2024 | Mar 31, 2024 | 22,760 | +4.0% | CVS Health 10-Q (2025-05-01) ↗ |
| Q4 2023 | Dec 31, 2023 | 24,146 | +11.5% | CVS Health 8-K (2025-02-12) ↗ |
| Q3 2023 | Sep 30, 2023 | 22,797 | +9.3% | CVS Health 10-Q (2024-11-06) ↗ |
| Q2 2023 | Jun 30, 2023 | 22,628 | +12.1% | CVS Health 10-Q (2024-08-07) ↗ |
| Q1 2023 | Mar 31, 2023 | 21,876 | +12.9% | CVS Health 10-Q (2024-05-01) ↗ |
| Q4 2022 | Dec 31, 2022 | 21,651 | +11.3% | CVS Health 8-K (2024-02-07) ↗ |
| Q3 2022 | Sep 30, 2022 | 20,849 | +13.4% | CVS Health 10-Q (2023-11-01) ↗ |
| Q2 2022 | Jun 30, 2022 | 20,181 | +12.4% | CVS Health 10-Q (2023-08-02) ↗ |
| Q1 2022 | Mar 31, 2022 | 19,382 | +13.7% | CVS Health 10-Q (2023-05-03) ↗ |
| Q4 2021 | Dec 31, 2021 | 19,457 | +10.6% | CVS Health 8-K (2023-02-08) ↗ |
| Q3 2021 | Sep 30, 2021 | 18,381 | +8.8% | CVS Health 10-Q (2022-11-02) ↗ |
| Q2 2021 | Jun 30, 2021 | 17,952 | +10.7% | CVS Health 10-Q (2022-08-03) ↗ |
| Q1 2021 | Mar 31, 2021 | 17,042 | +2.8% | CVS Health 10-Q (2022-05-04) ↗ |
| Q4 2020 | Dec 31, 2020 | 17,587 | +8.7% | CVS Health 8-K (2022-02-09) ↗ |
| Q3 2020 | Sep 30, 2020 | 16,899 | +7.9% | CVS Health 10-Q (2021-11-03) ↗ |
| Q2 2020 | Jun 30, 2020 | 16,220 | +4.3% | CVS Health 10-Q (2021-08-04) ↗ |
| Q1 2020 | Mar 31, 2020 | 16,578 | +8.4% | CVS Health 10-Q (2021-05-04) ↗ |
| Q4 2019 | Dec 31, 2019 | 16,184 | +3.8% | CVS Health 8-K (2021-02-16) ↗ |
| Q3 2019 | Sep 30, 2019 | 15,656 | +4.1% | CVS Health 10-Q (2020-11-06) ↗ |
| Q2 2019 | Jun 30, 2019 | 15,551 | – | CVS Health 10-Q (2020-08-05) ↗ |
| Q1 2019 | Mar 31, 2019 | 15,297 | – | CVS Health 10-Q (2020-05-06) ↗ |
| Q4 2018 | Dec 31, 2018 | 15,588 | – | CVS Health 8-K (2020-02-12) ↗ |
| Q3 2018 | Sep 30, 2018 | 15,042 | – | CVS Health 8-K (2019-11-06) ↗ |
Cite this data
StockData. (2026). Cvs Health Pharmacy & Consumer Wellness ($M), quarterly Q3 2018–Q2 2026 [Data set]. Compiled from Cvs Health SEC filings and investor materials. https://stockdatahq.com/stocks/cvs/kpis/pcw-cost-products
See every metric in the Cvs Health KPI table. Data updated Oct 28, 2026.